12 Literatur
-
1
Wallace W HB. et al .
Preservation of fertility in children treated for cancer.
Arch Dis Child.
2003;
88
493-496
-
2
Donnez J. et al .
Livebirth after orthotopic transplantation of cryopreserved ovarian tissue.
Lancet.
2004;
364
1405-1410
-
3
Duffner U. et al .
Late effects after therapy of childhood cancer.
Onkologie.
2000;
23
112-118
-
4
Goodwin P J.
Reversible ovarian ablation or chemotherapy: Are we ready for quality of life to guide adjuvant treatment decisions in breast cancer?.
J Clin Oncol.
2003;
21
4474-4475
-
5
Wallace W HB. et al .
The radiosensitivity of the human oocyte.
Hum Reprod.
2003;
18
117-121
-
6
Ganz P A. et al .
Breast cancer in younger women: Prospective randomized multicenter study on goserelin to prevent chemotherapy induced ovarian failure in young hormone insensitive reproductive and late health effects of treatment.
J Clin Oncol.
2003;
21
4184-4193
-
7
Ataya K. et al .
Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys.
Biol Reprod.
1995;
52
365-372
-
8
Sonmezer M, Oktay Kutlik.
Fertility preservation in female patients.
Hum Reprod Update.
2004;
10
251-266
-
9
Emig R. et al .
Ovarschutz und Fertilitätserhalt vor und während der Chemotherapie.
Geburtsh Frauenheilk.
2003;
63
574-576
-
10
Damewood M D, Grochow L B.
Prospects for fertility after chemotherapy or radiation for neoplastic disease.
Fertil Steril.
1986;
45
443-459
-
11
Kalantaridou S N. et al .
Premature ovarian failure.
Endocrinol Metab Clin North Am.
1998;
27
989-1006
-
12
Minton S E, Munster P N.
Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer.
Cancer Control.
2002;
9
466-472
-
13
Upponi S S. et al .
Pregnancy after breast cancer.
Eur J Cancer.
2003;
39
736-741
-
14
Meirow D.
Reproduction post-chemotherapy in young cancer patients.
Mol Cell Endocrinol.
2000;
169
123-131
-
15
Blakely L J. et al .
Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence.
Cancer.
2004;
100
465-469
-
16
Emens L A, Davidson N E.
Adjuvant hormonal therapy for premenopausal women with breast cancer.
Clin Cancer Res.
2003;
9
486-494
-
17
Nystedt M. et al .
Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study.
J Clin Oncol.
2003;
21
1836-1844
-
18
Fogelman I. et al .
Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF).
Osteoporos Int.
2003;
14
1001-1006
-
19
Tchen N. et al .
Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
J Clin Oncol.
2003;
21
4175-4183
-
20
De Haes H. et al .
Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the zoladex early breast cancer research association trialists group.
J Clin Oncol.
2003;
21
4510-4516
-
21
Vehmanen L, Saarto T, Elomaa I. et al .
Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment.
Eur J Cancer.
2001;
37
2373-2378
-
22
Simone J V.
Childhood leukemia - successes and challenges for survivors.
NEJM.
2003;
349
627-628
-
23
Oktay K, Buyuk E.
Ovarian transplantation in humans: indications, techniques and the risk of reseeding cancer.
Eur J Obst Gyn Reprod Biol.
2004;
113 (Suppl)
45-47
-
24
Gordts S, Campo R. et al .
Progress in transvaginal hydrolaparoscopy.
Obstet Gynecol Clin North Am.
2004;
31
631-639
-
25 Picton H M, Gosden R G, Leibo S P. Cryopreservation of oocytes and ovarian tissue. Vayena E, Rowe P, Griffin PD Current Practice and Controversies in Assisted Reproduction. Geneva; World Health Organization 2002: 142-151
-
26
Leibo S P, Mazur P.
The role of cooling rates in low-temperature preservation.
Cryobiology.
1971;
8
447-452
-
27
Siebzehnrubl E. et al .
Extension of the concept of extracorporeal fertilization by cryopreservation of impregnated oocytes.
Geburtsh Frauenheilk.
1993;
53
359-365
-
28
Martinez-Madrid B. et al .
Freeze-thawing intact human ovary with its vascular pedicle with a passive cooling device.
Fertil Steril.
2004;
82
1390-1394
-
29
Nawroth F. et al .
Die Vitrifikation.
Frauenarzt.
2005;
46
214-218
-
30
Blumfeld Z.
Gynaecologic concerns for young women exposed to gonadotoxic chemotherapy.
Curr Opin Obst Gynecol.
2003;
15
359-370
-
31
Chian R C.
In-vitro maturation of immature oocytes for infertile women with PCOS.
RBM-Online.
2004;
8
547-552
-
32
Gosden R G. et al .
Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C.
Hum Reprod.
1994;
9
597-603
-
33
Gosden R G. et al .
Follicular development from ovarian xenografts in SCID-mice.
J Reprod Fertil.
1994;
101
619-623
-
34
Oktay K, Aydin B A, Karlikaya G.
A technique for laparoscopic transplantation of frozen-banked ovarian tissue.
Fertil Steril.
2001;
75
1212-1216
-
35
Radford J A. et al .
Orthotopic reimplantation of cryopreserved ovarian cortical strips after high dose chemotherapy for Hodgkin's lymphoma.
Lancet.
2001;
357
1172-1175
-
36
Wells Jr S A. et al .
Transplantation of the parathyreoid glands in man: clinical indications and results.
Surgery.
1975;
78
34-44
-
37
Bosma G C. et al .
A severe combined immunodeficiency mutation in mouse.
Nature.
1983;
301
527-530
-
38
Waxman J H. et al .
Failure to preserve fertility in patients with Hodgkin's disease.
Cancer Chemother Pharmacol.
1987;
19
159-162
-
39
Kreuser E D. et al .
The role of LHRH-analogues in protecting gonadal functions during chemotherapy and irradiation.
Eur Urol.
1993;
23
157-163
-
40
Blumenfeld Z. et al .
Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy.
Hum Reprod.
1996;
11
1620-1626
-
41
Recchia F, Sica G. et al .
Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study.
Anticancer Drugs.
2002;
13
417-424
-
42
Schneider K TM.
Wissenschaftlich begründete moderne Geburtshilfe.
Gynäkologe.
2003;
35
840-844
-
43
Schmidt K LT. et al .
Orthotopic autotransplantation of cryopreserved ovarian tissue to woman cured of cancer - follicular growth, steroid production and oocyte retrival.
RBM-online.
2004;
8
448-453
-
44 http://www.baek.de/30/Richtlinien/Richtidx/Blutstam_pdf.pdf
-
45 Richtlinie zur Festlegung von Qualitäts- und Sicherheitsstandards für die Spende, Beschaffung, Testung, Verarbeitung, Konservierung, Lagerung und Verteilung von menschlichen Geweben und Zellen (2004/23/EG) http://europa.eu.int/scadplus/leg/de/cha/c11573.htm
.
-
46 Robert Koch Institut .Entwicklung der Überlebensraten von Krebspatienten in Deutschland. http://www.rki.de/cln_006/nn_226976/DE/Content/GBE/DachdokKrebs/Ueberlebensraten/brust,templateId=raw,property=publicationFile.pdf/brust 1999
-
47
Beckmann M W. et al .
Konsensusempfehlungen zur Hormontherapie (HT) im Klimakterium und in der Postmenopause - Im Auftrag des Vorstands der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe und im Konsens mit dem Berufsverband der Frauenärzte.
Geburtsh Frauenheilk.
2004;
64
1024-1028
-
48
Blakeley L J. et al .
Effects of Pregnancy after Treatment for Breast Carcinoma on Survival and Risk of Recurrence.
Cancer.
2004;
100
465-469
-
49
Wolff M, Strowitzki T.
Habituelle Aborte - ein multifaktorielles Krankeitsbild.
Gyn Endokrinol.
2005;
3
7-17
-
50
Babilas K, Ortmann O.
Ovarprotektion bei zytotoxischer Therapie.
Gynäkologe.
2005;
38
342-348
-
51
Silber S J, Lahnahan K M, Levine D J. et al .
Ovarian transplantation between monozygotic twins discordant for premature ovarian failure.
NEJM.
2005;
353
58-63
-
52
Leppä S, Saart T. et al .
Clondronate treatment influences MMP‐2 associated outcome in node positive breast cancer.
Breast Cancer Res Treat.
2005;
90
117-125
-
53
Wallace W HB, Anderson R A, Irvine S.
Fertility preservation for young patients with cancer: who is at risk and what can be offered?.
Lancet Oncology.
2005;
6
209-218
-
54
The Practice Committee of the American Society for Reproductive Medicine .
Ovarian tissue and oocyte cryopreservation.
Fertil Steril.
2005;
2
993-998
-
55
Meirow D, Lewron J, Eldar-Geva T.
Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy.
NEJM.
2005;
353
318-320
-
56
Maltaris T, Dimmler A, Müller A. et al .
The use of an open-freezing system with self-seeding for cryopreservation of mouse ovarian tissue.
Reprod Dom Anim.
2005;
40
250-254
-
57
Siebzehnrubl E, Kohl J, Dittrich R. et al .
Freezing of human ovarian tissue - not the oocytes but the granulosa is the problem.
Mol Cell Endocrinol.
2000;
169
109-111
-
58
Donnez J, Squifflet J, Dolmans M M. et al .
Orthotopic transplantation of fresh ovarian cortex: a report of two cases.
Fertil Steril.
2005;
84
1018e1-1018e3
-
59
Coticchio G, Bonu M A, Borini A. et al .
Oocyte cryopreservation: a biological perspective.
Eur J Obstet Gynecol Reprod Biol.
2004;
115 (Suppl 1)
2-7
-
60 Maltaris T, Kaya H. et al .Comparison of Xenografting in SCID Mice and LIVE/DEAD Assay as a Predictor of the Developmental Potential of Cryopreserved Ovarian Tissue in vivo. In press.
-
61 Biljan M M, Hemmings R, Brassard N. Fachinformation von Novartis. The Outcome of 150 Babies Following the Treatment With Letrozole or Letrozole and Gonadotropins. Montreal, PQ, Canada; Montreal Fertility Centre 9.12.2005
-
62 http://www.krebsgesellschaft.de/arbeitsgemeinschaft_gynaekologische_onkologie,18719.html; www.awmf-online.de
-
63
von Otte S, Schöpper B, Al Hassani S. et al .
In-vitro-Maturation. Eine Perspektive der assistierten Reproduktion.
Gynäkologe.
2004;
37
701-709
1 M. W. Beckmann und H. Binder trugen zu gleichen Anteilen zur Publikation bei
Dr. Helge Binder
Frauenklinik
Universitätsklinikum Erlangen
Universitätsstr. 21 - 23
91054 Erlangen
Email: helge.binder@gyn.imed.uni-erlangen.de
